<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer-Verlag</PublisherName>
    <PublisherLocation>New York</PublisherLocation>
  </PublisherInfo>
  <Journal>
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>12248</JournalID>
      <JournalElectronicISSN>1550-7416</JournalElectronicISSN>
      <JournalTitle>The AAPS Journal</JournalTitle>
      <JournalAbbreviatedTitle>AAPS J</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="F" Type="Primary">Pharmacy</JournalSubject>
        <JournalSubject Code="F00008" Priority="1" Type="Secondary">Pharmacy</JournalSubject>
        <JournalSubject Code="B21007" Priority="2" Type="Secondary">Pharmacology/Toxicology</JournalSubject>
        <JournalSubject Code="C12002" Priority="3" Type="Secondary">Biotechnology</JournalSubject>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume>
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>7</VolumeIDStart>
        <VolumeIDEnd>7</VolumeIDEnd>
        <VolumeIssueCount>4</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular">
        <IssueInfo TocLevels="0">
          <IssueIDStart>4</IssueIDStart>
          <IssueIDEnd>4</IssueIDEnd>
          <IssueArticleCount>15</IssueArticleCount>
          <IssueHistory>
            <CoverDate>
              <Year>2005</Year>
              <Month>12</Month>
            </CoverDate>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
            <CopyrightYear>2006</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="Art15">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>74922</ArticleID>
            <ArticleDOI>10.1208/aapsj070490</ArticleDOI>
            <ArticleSequenceNumber>15</ArticleSequenceNumber>
            <ArticleTitle Language="En">N-n-alkylnicotinium analogs, a novel class of antagonists at α4β2* Nicotinic acetylcholine receptors: Inhibition of S(-)-nicotine-evoked 86Rb+Efflux from rat thalamic synaptosomes</ArticleTitle>
            <ArticleFirstPage>E922</ArticleFirstPage>
            <ArticleLastPage>E930</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2008</Year>
                <Month>1</Month>
                <Day>23</Day>
              </RegistrationDate>
              <Received>
                <Year>2005</Year>
                <Month>8</Month>
                <Day>18</Day>
              </Received>
              <Accepted>
                <Year>2005</Year>
                <Month>9</Month>
                <Day>12</Day>
              </Accepted>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
              <CopyrightYear>2005</CopyrightYear>
            </ArticleCopyright>
            <ArticleGrants Type="Regular">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="Restricted"/>
              <BodyHTMLGrant Grant="Restricted"/>
              <BibliographyGrant Grant="Restricted"/>
              <ESMGrant Grant="Restricted"/>
            </ArticleGrants>
            <ArticleContext>
              <JournalID>12248</JournalID>
              <VolumeIDStart>7</VolumeIDStart>
              <VolumeIDEnd>7</VolumeIDEnd>
              <IssueIDStart>4</IssueIDStart>
              <IssueIDEnd>4</IssueIDEnd>
            </ArticleContext>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1" PresentAffiliationID="Aff2">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Lincoln</GivenName>
                  <GivenName>H.</GivenName>
                  <FamilyName>Wilkins</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff3">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Dennis</GivenName>
                  <GivenName>K.</GivenName>
                  <FamilyName>Miller</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff4">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Joshua</GivenName>
                  <GivenName>T.</GivenName>
                  <FamilyName>Ayers</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Peter</GivenName>
                  <GivenName>A.</GivenName>
                  <FamilyName>Crooks</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Linda</GivenName>
                  <GivenName>P.</GivenName>
                  <FamilyName>Dwoskin</FamilyName>
                </AuthorName>
                <Contact>
                  <Phone>(859) 257-4743</Phone>
                  <Fax>(859) 257-7564</Fax>
                  <Email>ldwoskin@email.uky.edu</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>College of Pharmacy</OrgDivision>
                <OrgName>University of Kentucky</OrgName>
                <OrgAddress>
                  <Postcode>40536-0082</Postcode>
                  <City>Lexington</City>
                  <State>KY</State>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff2">
                <OrgName>Bristol-Myers Squibb Co</OrgName>
                <OrgAddress>
                  <Street>309 Dove Park Road</Street>
                  <Postcode>70433</Postcode>
                  <City>Covington</City>
                  <State>LA</State>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff3">
                <OrgDivision>Department of Psychological Services</OrgDivision>
                <OrgName>University of Missouri</OrgName>
                <OrgAddress>
                  <Street>208 McAlester Hall</Street>
                  <Postcode>65211</Postcode>
                  <City>Columbia</City>
                  <State>MO</State>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff4">
                <OrgName>AstraZeneca</OrgName>
                <OrgAddress>
                  <Street>1800 Concord Pike</Street>
                  <Postbox>PO Box 15437</Postbox>
                  <Postcode>19850-5437</Postcode>
                  <City>Wilmington</City>
                  <State>DE</State>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En">
              <Heading>Abstract</Heading>
              <Para>Pyridine<Emphasis Type="Italic">N-n</Emphasis>-alkylation of S(-)-nicotine (NIC) affords<Emphasis Type="Italic">N-n</Emphasis>-alkylnicotinium analogs, previously shown to competitively inhibit [<Superscript>3</Superscript>H]NIC binding and interact with α4β2* nicotinic receptors (nAChRs). The present study determined the ability of the analogs to inhibit NIC-evoked<Superscript>86</Superscript>Rb<Superscript>+</Superscript> efflux from rat thalamic synaptosomes to assess functional interaction with α4β2* nAChRs. In a concentration-dependent manner, NIC evoked<Superscript>86</Superscript>Rb<Superscript>+</Superscript> efflux (EC<Subscript>50</Subscript>=170 nmol/L). Analoginduced inhibition of NIC-evoked<Superscript>86</Superscript>Rb<Superscript>+</Superscript> efflux varied over a ≈450-fold range. Analogs with long<Emphasis Type="Italic">n</Emphasis>-alkyl chain lengths (C<Subscript>9</Subscript>−C<Subscript>12</Subscript>) inhibited efflux in the low nmol/L range (IC<Subscript>50</Subscript>=9–20 nmol/L), similar to dihydro-β-erythroidine (IC<Subscript>50</Subscript>=19 nmol/L). Compounds with shorter<Emphasis Type="Italic">n</Emphasis>-alkyl chain lengths (C<Subscript>1</Subscript>−C<Subscript>8</Subscript>) produced inhibition in the low μmol/L range (IC<Subscript>50</Subscript> =3–12 μmol/L). C<Subscript>10</Subscript> and C<Subscript>12</Subscript> analogs completely inhibited NIC-evoked efflux, whereas C<Subscript>1–9</Subscript> analogs produced maximal inhibition of only 10% to 60%. While the C<Subscript>10</Subscript> analog<Emphasis Type="Italic">N-n</Emphasis>-decylnicotiniumiodide (NDNI) did not produce significant inhibition of NIC-evoked dopamine release in previously reported studies, NDNI possesses high affinity for [<Superscript>3</Superscript>H]NIC binding sites (K<Subscript>i</Subscript>=90 nmol/L) and is a potent and efficacious inhibitor of NIC-evoked<Superscript>86</Superscript>Rb<Superscript>+</Superscript> efflux as demonstrated in the current studies. Thus, NDNI is a competitive, selective antagonist at α4β2* nAChRs.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Keywords</Heading>
              <Keyword>nicotine analogs</Keyword>
              <Keyword>subtype-selectivity</Keyword>
              <Keyword>neuronal nicotinic receptor</Keyword>
            </KeywordGroup>
            <ArticleNote Type="Misc">
              <SimplePara>Published: January 13, 2006</SimplePara>
            </ArticleNote>
          </ArticleHeader>
          <BodyRef FileRef="BodyRef/PDF/12248_2008_Article_74922.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Itier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Bertrand</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Neuronal nicotinic receptors: from protein structure to function</ArticleTitle>
                  <JournalTitle>FEBS Lett.</JournalTitle>
                  <VolumeID>504</VolumeID>
                  <FirstPage>118</FirstPage>
                  <LastPage>125</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11532443</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0014-5793(01)02702-8</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXmsFelt7w%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Itier V, Bertrand D. Neuronal nicotinic receptors: from protein structure to function.<Emphasis Type="Italic">FEBS Lett.</Emphasis> 2001;504:118–125.</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Whiting</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Lindstrom</FamilyName>
                  </BibAuthorName>
                  <Year>1986</Year>
                  <ArticleTitle Language="En">Pharmacological properties of immunoisolated neuronal nicotinic receptors</ArticleTitle>
                  <JournalTitle>J Neurosci.</JournalTitle>
                  <VolumeID>6</VolumeID>
                  <FirstPage>3061</FirstPage>
                  <LastPage>3069</LastPage>
                  <Occurrence Type="PID">
                    <Handle>3531428</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL28XmtVektLY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Whiting P, Lindstrom J. Pharmacological properties of immunoisolated neuronal nicotinic receptors.<Emphasis Type="Italic">J Neurosci.</Emphasis> 1986;6:3061–3069.</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Whiting</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Lindstrom</FamilyName>
                  </BibAuthorName>
                  <Year>1987</Year>
                  <ArticleTitle Language="En">Purification and characterization of a nicotinic acetylcholine receptor from rat brain</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA.</JournalTitle>
                  <VolumeID>84</VolumeID>
                  <FirstPage>595</FirstPage>
                  <LastPage>599</LastPage>
                  <Occurrence Type="PID">
                    <Handle>3467376</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.84.2.595</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL2sXps1Ogsg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Whiting P, Lindstrom J. Purification and characterization of a nicotinic acetylcholine receptor from rat brain.<Emphasis Type="Italic">Proc Natl Acad Sci USA.</Emphasis> 1987;84:595–599.</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CM</Initials>
                    <FamilyName>Flores</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SW</Initials>
                    <FamilyName>Rogers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LA</Initials>
                    <FamilyName>Pabreza</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BB</Initials>
                    <FamilyName>Wolfe</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KJ</Initials>
                    <FamilyName>Kellar</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">A subtype of nicotinic cholinergic receptor in brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment</ArticleTitle>
                  <JournalTitle>Mol Pharmacol.</JournalTitle>
                  <VolumeID>41</VolumeID>
                  <FirstPage>31</FirstPage>
                  <LastPage>37</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1732720</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK38Xls1Cmu7s%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Flores CM, Rogers SW, Pabreza LA, Wolfe BB, Kellar KJ. A subtype of nicotinic cholinergic receptor in brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.<Emphasis Type="Italic">Mol Pharmacol.</Emphasis> 1992;41:31–37.</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MR</Initials>
                    <FamilyName>Picciotto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Zoli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Lena</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain</ArticleTitle>
                  <JournalTitle>Nature.</JournalTitle>
                  <VolumeID>374</VolumeID>
                  <FirstPage>65</FirstPage>
                  <LastPage>67</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7870173</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/374065a0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXktFCrt78%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Picciotto MR, Zoli M, Lena C, et al. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain.<Emphasis Type="Italic">Nature.</Emphasis> 1995;374:65–67.</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Zoli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Lena</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MR</Initials>
                    <FamilyName>Picciotto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J-P</Initials>
                    <FamilyName>Changeux</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Identification of 4 classes of brain nicotinic receptors using beta2 mutant mice</ArticleTitle>
                  <JournalTitle>J Neurosci.</JournalTitle>
                  <VolumeID>18</VolumeID>
                  <FirstPage>4461</FirstPage>
                  <LastPage>4472</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9614223</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXjslGjsLk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zoli M, Lena C, Picciotto MR, Changeux J-P. Identification of 4 classes of brain nicotinic receptors using beta2 mutant mice.<Emphasis Type="Italic">J Neurosci.</Emphasis> 1998;18:4461–4472.</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Marks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Stitzel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SR</Initials>
                    <FamilyName>Grady</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MR</Initials>
                    <FamilyName>Picciotto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JP</Initials>
                    <FamilyName>Changeux</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AC</Initials>
                    <FamilyName>Collins</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Nicotinic-agonist stimulated<Superscript>86</Superscript>Rb<Superscript>+</Superscript> efflux and [<Superscript>3</Superscript>H]epibatidine binding of mice differing in β2 genotype</ArticleTitle>
                  <JournalTitle>Neuropharmacology</JournalTitle>
                  <VolumeID>39</VolumeID>
                  <FirstPage>2632</FirstPage>
                  <LastPage>2645</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11044733</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0028-3908(00)00115-5</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXntlGqsLs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Marks MJ, Stitzel JA, Grady SR, Picciotto MR, Changeux JP, Collins AC. Nicotinic-agonist stimulated<Superscript>86</Superscript>Rb<Superscript>+</Superscript> efflux and [<Superscript>3</Superscript>H]epibatidine binding of mice differing in β2 genotype.<Emphasis Type="Italic">Neuropharmacology</Emphasis>. 2000;39:2632–2645.</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Marks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Whiteaker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SR</Initials>
                    <FamilyName>Grady</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MR</Initials>
                    <FamilyName>Picciotto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>McIntosh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AC</Initials>
                    <FamilyName>Collins</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Characterization of [(125)I]epibatidine binding and nicotinic agonist-mediated (86)Rb(+) efflux in interpeduncular nucleus and inferior colliculus of beta2 null mutant mice</ArticleTitle>
                  <JournalTitle>J Neurochem.</JournalTitle>
                  <VolumeID>81</VolumeID>
                  <FirstPage>1102</FirstPage>
                  <LastPage>1115</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12065623</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1471-4159.2002.00910.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XksV2hs7c%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Marks MJ, Whiteaker P, Grady SR, Picciotto MR, McIntosh JM, Collins AC. Characterization of [(125)I]epibatidine binding and nicotinic agonist-mediated (86)Rb(+) efflux in interpeduncular nucleus and inferior colliculus of beta2 null mutant mice.<Emphasis Type="Italic">J Neurochem.</Emphasis> 2002;81:1102–1115.</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Marks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DA</Initials>
                    <FamilyName>Farnham</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SR</Initials>
                    <FamilyName>Grady</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AC</Initials>
                    <FamilyName>Collins</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>264</VolumeID>
                  <FirstPage>542</FirstPage>
                  <LastPage>552</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8437106</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXhs1Wls7w%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Marks MJ, Farnham DA, Grady SR, Collins AC. Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1993;264:542–552.</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Marks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Whiteaker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Calcaterra</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>289</VolumeID>
                  <FirstPage>1090</FirstPage>
                  <LastPage>1103</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10215692</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXislGisbw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Marks MJ, Whiteaker P, Calcaterra J, et al. Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1999;289:1090–1103.</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>HN</Initials>
                    <FamilyName>Nguyen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BA</Initials>
                    <FamilyName>Rasmussen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DC</Initials>
                    <FamilyName>Perry</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Binding and functional activity of nicotinic cholinergic receptors in selected rat brain regions are increased following long-term but not short-term nicotine treatment</ArticleTitle>
                  <JournalTitle>J Neurochem.</JournalTitle>
                  <VolumeID>90</VolumeID>
                  <FirstPage>40</FirstPage>
                  <LastPage>49</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15198665</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1471-4159.2004.02482.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXlvFKls74%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nguyen HN, Rasmussen BA, Perry DC. Binding and functional activity of nicotinic cholinergic receptors in selected rat brain regions are increased following long-term but not short-term nicotine treatment.<Emphasis Type="Italic">J Neurochem.</Emphasis> 2004;90:40–49.</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JB</Initials>
                    <FamilyName>Eaton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Peng</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KM</Initials>
                    <FamilyName>Schroeder</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Characterization of human α4β2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cells</ArticleTitle>
                  <JournalTitle>Mol Pharmacol.</JournalTitle>
                  <VolumeID>64</VolumeID>
                  <FirstPage>1283</FirstPage>
                  <LastPage>1294</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14645658</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/mol.64.6.1283</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXps1OitLY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Eaton JB, Peng JH, Schroeder KM, et al. Characterization of human α4β2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cells.<Emphasis Type="Italic">Mol Pharmacol.</Emphasis> 2003;64:1283–1294.</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MS</Initials>
                    <FamilyName>Karadsheh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MS</Initials>
                    <FamilyName>Shah</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>X</Initials>
                    <FamilyName>Tang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RL</Initials>
                    <FamilyName>Macdonald</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Stitzel</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Functional characterization of mouse α4β2 nicotinic acetylcholine receptors stably expressed in HEK293T cells</ArticleTitle>
                  <JournalTitle>J Neurochem.</JournalTitle>
                  <VolumeID>91</VolumeID>
                  <FirstPage>1138</FirstPage>
                  <LastPage>1150</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15569257</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1471-4159.2004.02801.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXhtFSitr7O</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Karadsheh MS, Shah MS, Tang X, Macdonald RL, Stitzel JA. Functional characterization of mouse α4β2 nicotinic acetylcholine receptors stably expressed in HEK293T cells.<Emphasis Type="Italic">J Neurochem.</Emphasis> 2004;91:1138–1150.</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MW</Initials>
                    <FamilyName>Decker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DJ</Initials>
                    <FamilyName>Anderson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Brioni</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Erysodine, a competitive antagonist at neuronal nicotinic acetylcholine receptors</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol.</JournalTitle>
                  <VolumeID>280</VolumeID>
                  <FirstPage>79</FirstPage>
                  <LastPage>89</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7498257</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0014-2999(95)00191-M</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXmsVWgurg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Decker MW, Anderson DJ, Brioni JD, et al. Erysodine, a competitive antagonist at neuronal nicotinic acetylcholine receptors.<Emphasis Type="Italic">Eur J Pharmacol.</Emphasis> 1995;280:79–89.</BibUnstructured>
              </Citation>
              <Citation ID="CR15">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Puttfarcken</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AM</Initials>
                    <FamilyName>Manelli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SP</Initials>
                    <FamilyName>Arneric</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DL</Initials>
                    <FamilyName>Donnelly-Roberts</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Evidence for nicotinic receptors potentially modulating nociceptive transmission at the level of the primary sensory neuron: studies with F11 cells</ArticleTitle>
                  <JournalTitle>J Neurochem.</JournalTitle>
                  <VolumeID>69</VolumeID>
                  <FirstPage>930</FirstPage>
                  <LastPage>938</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9282914</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXls1Chtrg%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1046/j.1471-4159.1997.69030930.x</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Puttfarcken PS, Manelli AM, Arneric SP, Donnelly-Roberts DL. Evidence for nicotinic receptors potentially modulating nociceptive transmission at the level of the primary sensory neuron: studies with F11 cells.<Emphasis Type="Italic">J Neurochem.</Emphasis> 1997;69:930–938.</BibUnstructured>
              </Citation>
              <Citation ID="CR16">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Xiao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EL</Initials>
                    <FamilyName>Meyer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Thompson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Surin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Wroblewski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KJ</Initials>
                    <FamilyName>Kellar</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function</ArticleTitle>
                  <JournalTitle>Mol Pharmacol.</JournalTitle>
                  <VolumeID>54</VolumeID>
                  <FirstPage>322</FirstPage>
                  <LastPage>333</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9687574</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXlsVWls78%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Xiao Y, Meyer EL, Thompson JM, Surin A, Wroblewski J, Kellar KJ. Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function.<Emphasis Type="Italic">Mol Pharmacol.</Emphasis> 1998;54:322–333.</BibUnstructured>
              </Citation>
              <Citation ID="CR17">
                <CitationNumber>17.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SC</Initials>
                    <FamilyName>Hernandez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Bertolino</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Xiao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KE</Initials>
                    <FamilyName>Pringle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FS</Initials>
                    <FamilyName>Caruso</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KJ</Initials>
                    <FamilyName>Kellar</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Dextromethorphan and its metabolite dextrorphan block α3β4 neuronal nicotinic receptors</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>293</VolumeID>
                  <FirstPage>962</FirstPage>
                  <LastPage>967</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10869398</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXjsleksbk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hernandez SC, Bertolino M, Xiao Y, Pringle KE, Caruso FS, Kellar KJ. Dextromethorphan and its metabolite dextrorphan block α3β4 neuronal nicotinic receptors.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2000;293:962–967.</BibUnstructured>
              </Citation>
              <Citation ID="CR18">
                <CitationNumber>18.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Lukas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Fryer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Eaton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Gentry</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ChapterTitle Language="En">Some methods for studies of nicotinic acetylcholine receptor pharmacology</ChapterTitle>
                  <BibEditorName>
                    <Initials>ED</Initials>
                    <FamilyName>Levin</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Nicotinic Receptors and the Nervous System</BookTitle>
                  <PublisherName>CRC Press</PublisherName>
                  <PublisherLocation>Boca Raton, FL</PublisherLocation>
                  <FirstPage>3</FirstPage>
                  <LastPage>27</LastPage>
                </BibChapter>
                <BibUnstructured>Lukas R, Fryer J, Eaton J, Gentry C. Some methods for studies of nicotinic acetylcholine receptor pharmacology. In: Levin ED, ed.<Emphasis Type="Italic">Nicotinic Receptors and the Nervous System</Emphasis>. Boca Raton, FL: CRC Press, 2002:3–27.</BibUnstructured>
              </Citation>
              <Citation ID="CR19">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Crooks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Ravard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LH</Initials>
                    <FamilyName>Wilkins</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L-H</Initials>
                    <FamilyName>Teng</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ST</Initials>
                    <FamilyName>Buxton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Dwoskin</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Inhibition of nicotine-evoked [<Superscript>3</Superscript>H]dopamine release by pyridine<Emphasis Type="Italic">N</Emphasis>-substituted nicotine analogues: a new class of nicotinic antagonist</ArticleTitle>
                  <JournalTitle>Drug Dev Res.</JournalTitle>
                  <VolumeID>36</VolumeID>
                  <FirstPage>91</FirstPage>
                  <LastPage>102</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/ddr.430360204</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXptVyms7o%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Crooks PA, Ravard A, Wilkins LH, Teng L-H, Buxton ST, Dwoskin LP. Inhibition of nicotine-evoked [<Superscript>3</Superscript>H]dopamine release by pyridine<Emphasis Type="Italic">N</Emphasis>-substituted nicotine analogues: a new class of nicotinic antagonist.<Emphasis Type="Italic">Drug Dev Res.</Emphasis> 1995;36:91–102.</BibUnstructured>
              </Citation>
              <Citation ID="CR20">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Dwoskin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Xu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JT</Initials>
                    <FamilyName>Ayers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Crooks</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Recent developments in neuronal nicotinic acetylcholine receptor antagonists</ArticleTitle>
                  <JournalTitle>Curr Opin Ther Patents.</JournalTitle>
                  <VolumeID>10</VolumeID>
                  <FirstPage>1561</FirstPage>
                  <LastPage>1581</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1517/13543776.10.10.1561</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXnt1antrk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dwoskin LP, Xu R, Ayers JT, Crooks PA. Recent developments in neuronal nicotinic acetylcholine receptor antagonists.<Emphasis Type="Italic">Curr Opin Ther Patents.</Emphasis> 2000;10:1561–1581.</BibUnstructured>
              </Citation>
              <Citation ID="CR21">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Dwoskin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Crooks</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>298</VolumeID>
                  <FirstPage>395</FirstPage>
                  <LastPage>402</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11454899</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXlsVKqsrg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dwoskin LP, Crooks PA. Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2001;298:395–402.</BibUnstructured>
              </Citation>
              <Citation ID="CR22">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LH</Initials>
                    <FamilyName>Wilkins</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Haubner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JT</Initials>
                    <FamilyName>Ayers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Crooks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Dwoskin</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">
                    <Emphasis Type="Italic">N-n</Emphasis>-Alkylnicotinium analogs, a novel class of nicotinic receptor antagonist: inhibition of S-(-)-nicotine-evoked [<Superscript>3</Superscript>H]dopamine overflow from superfused rat striatal slices</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>301</VolumeID>
                  <FirstPage>1088</FirstPage>
                  <LastPage>1096</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12023541</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.301.3.1088</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XktlGjsbk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wilkins LH, Haubner A, Ayers JT, Crooks PA, Dwoskin LP.<Emphasis Type="Italic">N-n</Emphasis>-Alkylnicotinium analogs, a novel class of nicotinic receptor antagonist: inhibition of S-(-)-nicotine-evoked [<Superscript>3</Superscript>H]dopamine overflow from superfused rat striatal slices.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2002;301:1088–1096.</BibUnstructured>
              </Citation>
              <Citation ID="CR23">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LH</Initials>
                    <FamilyName>Wilkins</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VP</Initials>
                    <FamilyName>Grinevich</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JT</Initials>
                    <FamilyName>Ayers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Crooks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Dwoskin</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">
                    <Emphasis Type="Italic">N-n</Emphasis>-Alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with α4β2<Superscript>*</Superscript> and α7<Superscript>*</Superscript> neuronal nicotinic receptors</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>304</VolumeID>
                  <FirstPage>400</FirstPage>
                  <LastPage>410</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12490617</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.102.043349</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXht1SntA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wilkins LH, Grinevich VP, Ayers JT, Crooks PA, Dwoskin LP.<Emphasis Type="Italic">N-n</Emphasis>-Alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with α4β2<Superscript>*</Superscript> and α7<Superscript>*</Superscript> neuronal nicotinic receptors.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2003;304:400–410.</BibUnstructured>
              </Citation>
              <Citation ID="CR24">
                <CitationNumber>24.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Xu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Dwoskin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Grinevich</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SP</Initials>
                    <FamilyName>Sumithran</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Crooks</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Synthesis and evaluation of conformationally restricted pyridine<Emphasis Type="Italic">N</Emphasis>-alkylated nicotine analogs as nicotinic acetylcholine receptor antagonists</ArticleTitle>
                  <JournalTitle>Drug Dev Res.</JournalTitle>
                  <VolumeID>55</VolumeID>
                  <FirstPage>173</FirstPage>
                  <LastPage>186</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/ddr.10049</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XksVyks7c%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Xu R, Dwoskin LP, Grinevich V, Sumithran SP, Crooks PA. Synthesis and evaluation of conformationally restricted pyridine<Emphasis Type="Italic">N</Emphasis>-alkylated nicotine analogs as nicotinic acetylcholine receptor antagonists.<Emphasis Type="Italic">Drug Dev Res.</Emphasis> 2002;55:173–186.</BibUnstructured>
              </Citation>
              <Citation ID="CR25">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DD</Initials>
                    <FamilyName>Allen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PR</Initials>
                    <FamilyName>Lockman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KE</Initials>
                    <FamilyName>Roder</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Dwoskin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Crooks</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Active transport of high affinity choline and nicotine analogs into the central nervous system by the blood-brain barrier choline transporter</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>304</VolumeID>
                  <FirstPage>1268</FirstPage>
                  <LastPage>1274</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12604705</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.102.045856</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXit1eisLo%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Allen DD, Lockman PR, Roder KE, Dwoskin LP, Crooks PA. Active transport of high affinity choline and nicotine analogs into the central nervous system by the blood-brain barrier choline transporter.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2003;304:1268–1274.</BibUnstructured>
              </Citation>
              <Citation ID="CR26">
                <CitationNumber>26.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Crooks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JT</Initials>
                    <FamilyName>Ayers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Xu</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Development of subtype selective ligands as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release</ArticleTitle>
                  <JournalTitle>Bioorg Med Chem Lett.</JournalTitle>
                  <VolumeID>14</VolumeID>
                  <FirstPage>1869</FirstPage>
                  <LastPage>1874</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15050618</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.bmcl.2003.10.074</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXislSqtbs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Crooks PA, Ayers JT, Xu R, et al. Development of subtype selective ligands as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release.<Emphasis Type="Italic">Bioorg Med Chem Lett.</Emphasis> 2004;14:1869–1874.</BibUnstructured>
              </Citation>
              <Citation ID="CR27">
                <CitationNumber>27.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Marks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SF</Initials>
                    <FamilyName>Robinson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AC</Initials>
                    <FamilyName>Collins</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Nicotinic agonists differ in activation and desensitization of<Superscript>86</Superscript>Rb<Superscript>+</Superscript> efflux from mouse thalamic synaptosomes</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>277</VolumeID>
                  <FirstPage>1383</FirstPage>
                  <LastPage>1396</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8667201</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XjslGlt7Y%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Marks MJ, Robinson SF, Collins AC. Nicotinic agonists differ in activation and desensitization of<Superscript>86</Superscript>Rb<Superscript>+</Superscript> efflux from mouse thalamic synaptosomes.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1996;277:1383–1396.</BibUnstructured>
              </Citation>
              <Citation ID="CR28">
                <CitationNumber>28.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Ramirez-Latorre</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CR</Initials>
                    <FamilyName>Yu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>X</Initials>
                    <FamilyName>Qu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Perin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Karlin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Role</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Functional contributions of alpha5 subunit to neuronal acetylcholine receptor channels</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>380</VolumeID>
                  <FirstPage>347</FirstPage>
                  <LastPage>351</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8598930</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/380347a0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XhvFyrt7Y%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ramirez-Latorre J, Yu CR, Qu X, Perin F, Karlin A, Role L. Functional contributions of alpha5 subunit to neuronal acetylcholine receptor channels.<Emphasis Type="Italic">Nature</Emphasis>. 1996;380:347–351.</BibUnstructured>
              </Citation>
              <Citation ID="CR29">
                <CitationNumber>29.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Goldman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Deneris</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Luyten</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Kochhar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Patrick</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Heinemann</FamilyName>
                  </BibAuthorName>
                  <Year>1987</Year>
                  <ArticleTitle Language="En">Members of a nicotinic acetylcholine receptor gene family are expressed in different regions of the mammalian central nervous system</ArticleTitle>
                  <JournalTitle>Cell.</JournalTitle>
                  <VolumeID>48</VolumeID>
                  <FirstPage>965</FirstPage>
                  <LastPage>973</LastPage>
                  <Occurrence Type="PID">
                    <Handle>3829125</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0092-8674(87)90705-7</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1cXltVCqsA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Goldman D, Deneris E, Luyten W, Kochhar A, Patrick J, Heinemann S. Members of a nicotinic acetylcholine receptor gene family are expressed in different regions of the mammalian central nervous system.<Emphasis Type="Italic">Cell.</Emphasis> 1987;48:965–973.</BibUnstructured>
              </Citation>
              <Citation ID="CR30">
                <CitationNumber>30.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>ZJ</Initials>
                    <FamilyName>Yu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DG</Initials>
                    <FamilyName>Morgan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Wecker</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Distribution of 3 nicotinic receptor alpha 4 mRNA transcripts in rat brain: selective regulation by nicotine administration</ArticleTitle>
                  <JournalTitle>J Neurochem.</JournalTitle>
                  <VolumeID>66</VolumeID>
                  <FirstPage>1326</FirstPage>
                  <LastPage>1329</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8769902</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28Xht1Oht70%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Yu ZJ, Morgan DG, Wecker L. Distribution of 3 nicotinic receptor alpha 4 mRNA transcripts in rat brain: selective regulation by nicotine administration.<Emphasis Type="Italic">J Neurochem.</Emphasis> 1996;66:1326–1329.</BibUnstructured>
              </Citation>
              <Citation ID="CR31">
                <CitationNumber>31.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Stitzel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Dobelis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Jimenez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AC</Initials>
                    <FamilyName>Collins</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Long sleep and short sleep mice differ in nicotine-stimulated<Superscript>86</Superscript>Rb<Superscript>+</Superscript> efflux and α4 nicotinic receptor subunit cDNA sequence</ArticleTitle>
                  <JournalTitle>Pharmacogenetics</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <FirstPage>331</FirstPage>
                  <LastPage>339</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11434511</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00008571-200106000-00008</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXkvFeis7s%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Stitzel JA, Dobelis P, Jimenez M, Collins AC. Long sleep and short sleep mice differ in nicotine-stimulated<Superscript>86</Superscript>Rb<Superscript>+</Superscript> efflux and α4 nicotinic receptor subunit cDNA sequence.<Emphasis Type="Italic">Pharmacogenetics</Emphasis>. 2001;11:331–339.</BibUnstructured>
              </Citation>
              <Citation ID="CR32">
                <CitationNumber>32.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Dobelis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Marks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Whiteaker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Balogh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AC</Initials>
                    <FamilyName>Collins</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Stitzel</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">A polymorphism in the mouse neuronal α4 nicotinic receptor subunit results in an alteration in receptor function</ArticleTitle>
                  <JournalTitle>Mol Pharmacol.</JournalTitle>
                  <VolumeID>62</VolumeID>
                  <FirstPage>334</FirstPage>
                  <LastPage>342</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12130686</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/mol.62.2.334</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XlslOrs7o%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dobelis P, Marks MJ, Whiteaker P, Balogh SA, Collins AC, Stitzel JA. A polymorphism in the mouse neuronal α4 nicotinic receptor subunit results in an alteration in receptor function.<Emphasis Type="Italic">Mol Pharmacol.</Emphasis> 2002;62:334–342.</BibUnstructured>
              </Citation>
              <Citation ID="CR33">
                <CitationNumber>33.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Zwart</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HP</Initials>
                    <FamilyName>Vijverberg</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Four pharmacologically distinct subtypes of α4β2 nicotinic acetylcholine receptor expressed in<Emphasis Type="Italic">Xenopus laevis</Emphasis> oocytes</ArticleTitle>
                  <JournalTitle>Mol Pharmacol.</JournalTitle>
                  <VolumeID>54</VolumeID>
                  <FirstPage>1124</FirstPage>
                  <LastPage>1131</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9855643</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXptVai</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zwart R, Vijverberg HP. Four pharmacologically distinct subtypes of α4β2 nicotinic acetylcholine receptor expressed in<Emphasis Type="Italic">Xenopus laevis</Emphasis> oocytes.<Emphasis Type="Italic">Mol Pharmacol.</Emphasis> 1998;54:1124–1131.</BibUnstructured>
              </Citation>
              <Citation ID="CR34">
                <CitationNumber>34.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Liu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Nordberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>X</Initials>
                    <FamilyName>Zhang</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Differential co-expression of nicotinic acetylcholine receptor alpha 4 and beta 2 subunit genes in various regions of rat brain</ArticleTitle>
                  <JournalTitle>Neuroreport</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <FirstPage>1645</FirstPage>
                  <LastPage>1649</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8904774</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XmsFers7s%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00001756-199607080-00024</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Liu C, Nordberg A, Zhang X. Differential co-expression of nicotinic acetylcholine receptor alpha 4 and beta 2 subunit genes in various regions of rat brain.<Emphasis Type="Italic">Neuroreport</Emphasis>. 1996;7:1645–1649.</BibUnstructured>
              </Citation>
              <Citation ID="CR35">
                <CitationNumber>35.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Katz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Thesleff</FamilyName>
                  </BibAuthorName>
                  <Year>1957</Year>
                  <ArticleTitle Language="En">A study of the “desensitization” produced by acetylcholine at the motor end-plate</ArticleTitle>
                  <JournalTitle>J Physiol.</JournalTitle>
                  <VolumeID>138</VolumeID>
                  <FirstPage>63</FirstPage>
                  <LastPage>80</LastPage>
                  <Occurrence Type="PID">
                    <Handle>13463799</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaG1c%2Fgs1Cmug%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Katz B, Thesleff S. A study of the “desensitization” produced by acetylcholine at the motor end-plate.<Emphasis Type="Italic">J Physiol.</Emphasis> 1957;138:63–80.</BibUnstructured>
              </Citation>
              <Citation ID="CR36">
                <CitationNumber>36.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SJ</Initials>
                    <FamilyName>Edelstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Schaad</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Henry</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Bertrand</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JP</Initials>
                    <FamilyName>Changeux</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">A kinetic mechanism for nicotinic acetylcholine receptors based on multiple allosteric transitions</ArticleTitle>
                  <JournalTitle>Biol Cybern.</JournalTitle>
                  <VolumeID>75</VolumeID>
                  <FirstPage>361</FirstPage>
                  <LastPage>379</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8983160</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/s004220050302</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2s7jslyhsQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Edelstein SJ, Schaad O, Henry E, Bertrand D, Changeux JP. A kinetic mechanism for nicotinic acetylcholine receptors based on multiple allosteric transitions.<Emphasis Type="Italic">Biol Cybern.</Emphasis> 1996;75:361–379.</BibUnstructured>
              </Citation>
              <Citation ID="CR37">
                <CitationNumber>37.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Karlin</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Emerging structure of the nicotinic acetylcholine receptors</ArticleTitle>
                  <JournalTitle>Nat Rev Neurosci.</JournalTitle>
                  <VolumeID>3</VolumeID>
                  <FirstPage>102</FirstPage>
                  <LastPage>114</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11836518</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/nrn731</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xhslyju7Y%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Karlin A. Emerging structure of the nicotinic acetylcholine receptors.<Emphasis Type="Italic">Nat Rev Neurosci.</Emphasis> 2002;3:102–114.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
